The U.S. Food and Drug Administration said on Wednesday its outside advisers will meet on Sept. 17 to discuss additional doses of COVID-19 vaccines and specifically Pfizer Inc (PFE.N) and partner BioNTech's (22UAy.DE) application for the use of a booster vaccine dose.